Familial occurrence of tumours of the choroid plexus.

por Zwetsloot, C P, Kros, J M, Paz y Gueze, H D
Publicado 1991

Development of the anterior cingulate syndrome in a child due to delayed necrotising methotrexate leukoencephalopathy.

por Catsman-Berrevoets, C E, van Dongen, H R, Kros, J M
Publicado 1997

P11.11 Circulating Pro-Angiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regener...

por Huizer, K, Sacchetti, A, Dik, W, Kros, J M, Mustafa, D
Publicado en Neuro Oncol (2019)

P08.31 Periostin is expressed by pericytes and promotes angiogenesis under the control of glial tumor cells

por Kros, J. M., Huizer, K., Zhu, C., Cheng, C., Mustafa, D. A. M.
Publicado en Neuro Oncol (2017)

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery

por van Veelen, M L C, Avezaat, C, Kros, J, van Putten, W, Vecht, C.
Publicado 1998

P11.12 Periostin is expressed by pericytes and is crucial for angiogenesis in glioma

por Huizer, K, Kros, J M, Zhu, C, Chirifi, I, Krist, B, Cheng, C, Mustafa, D
Publicado en Neuro Oncol (2019)

P11.10 The IFNγ pathway mediates brain metastasis formation of breast cancer

por Pedrosa, R, Kros, J M, Schrijver, B, Marques, R, Leenen, P, Dik, W, van Eijck, C, Mustafa, D
Publicado en Neuro Oncol (2019)

A neuroimaging follow up study of a patient with juvenile central nervous system systemic lupus erythematosus

por Steens, S, Bosma, G, ten, C, Doornbos, J, Kros, J, Laan, L, Steup-Beekman, G, van Buchem, M A, Huizinga, T
Publicado 2003

Correlation of in vitro infiltration with glioma histological type in organotypic brain slices

por Palfi, S, Swanson, K R, de Boüard, S, Chrétien, F, Oliveira, R, Gherardi, R K, Kros, J M, Peschanski, M, Christov, C
Publicado 2004

CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma

por Zhu, C, Chrifi, I, Mustafa, D, van der Weiden, M, Leenen, P J M, Duncker, D J, Kros, J M, Cheng, C
Publicado en Oncogene (2017)

P01.066 Patients with EGFR amplification but without EGFRvIII expression have improved benefit compared to those with EGFRvIII expression in samples of the INTELLANCE 2/EORTC 1410...

por French, P J, Kros, J, de Heer, I, Ansell, P, Looman, J, Bain, E, Morfouace, M, Gorlia, T, Golfinopoulos, V, van den Bent, M
Publicado en Neuro Oncol (2018)

OS03.1 The role of the immune system in facilitating the formation of brain metastasis of breast cancer

por Mustafa, D. A. M., Pedrosa, R. M., Sieuwerts, A., Smid, M., de Weerd, V., Luider, T., Debets, R., Martens, J., Foekens, J., Kros, J. M.
Publicado en Neuro Oncol (2017)

EH1.1 Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion, an int...

por van den Bent, M. J., Erridge, S., Vogelbaum, M., Nowak, A., Sanson, M., Brandes, A. A., Golfinopoulos, V., Gorlia, T., Kros, J. M., Baumert, B. G.
Publicado en Neuro Oncol (2016)

OS5.3 Stability of actionable mutations in primary and recurrent glioblastomas

por Draaisma, K., Taphoorn, M., Weyerbrock, A., Sanson, M., Gorlia, T., Golfinopoulos, V., Kros, J. M., Robe, P. A., van den Bent, M. M. J., French, P. J.
Publicado en Neuro Oncol (2016)

The complement system in glioblastoma multiforme

por Bouwens van der Vlis, T. A. M., Kros, J. M., Mustafa, D. A. M., van Wijck, R. T. A., Ackermans, L., van Hagen, P. M., van der Spek, P. J.
Publicado en Acta Neuropathol Commun (2018)

OS10.1 Survival analysis of IDH wildtype astrocytomas with molecular features of glioblastoma, WHO grade IV

por Tesileanu, C M S, Koekkoek, J A F, Dirven, L, Dubbink, H J, Kros, J M, van Duinen, S G, Smits, M, French, P J, Taphoorn, M J B, van den Bent, M J
Publicado en Neuro Oncol (2019)

P04.11 Voxelwise correlation between vascular MRI parameters obtained with ASL and DSC is decreased in IDH-wt non-enhancing glioma

por Warnert, E A H, Incekara, F, Vincent, A J P E, Schouten, J W, van den Bent, M J, French, P J, Dubbink, H J, Kros, J M, Hernandez-Tamames, J A, Smits, M
Publicado en Neuro Oncol (2019)

P11.08 Defining EGFR amplification status for clinical trial inclusion

por French, P, Eoli, M, Sepulveda, J, de Heer, I, Kros, J M, Walenkamp, A, Frenel, J, Franceschi, E, Clement, P, Weller, M, Ansell, P, Looman, J, Bain, E, Morfouace, M, Gorlia, T, van den Bent, M
Publicado en Neuro Oncol (2019)

IDENTIFICATION OF PATIENTS WITH RECURRENT GBM THAT BENEFIT FROM BEVACIZUMAB

por French, Pim, Erdem-Eraslan, L., Kros, J.M., Oosterkamp, H.M., Walenkamp, A.M.E., Beerepoot, L., Hanse, M., Buter, J., Honkoop, A., van der Holt, B., Vernhout, R.M., Sillevis Smitt, P.A.E., Taal, W., van den Bent, M.J.
Publicado 2014

PL3.3 Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/...

por van den Bent, M J, Erridge, S, Vogelbaum, M A, Nowak, A K, Sanson, M, Brandes, A A, Wick, W, Clement, P M, Baurain, J F, Mason, W, Wheeler, H, Weller, M, Aldape, K, Wesseling, P, Kros, J M, Tesileanu, C M S, Golfinopoulos, V, Gorlia, T, Baumert, B G, French, P J
Publicado en Neuro Oncol (2019)